Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets. 1985

F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro

To examine the bioavailability of nitroglycerin in sublingual tablet, 5 healthy adult volunteers underwent simultaneous sublingual administration of a tablet prepared with methylcellulose and a tablet prepared with lactose containing 0.15 mg of nitroglycerin and 0.15 mg of nitroglycerin-15N3, respectively. In 4 of 5 volunteers, no difference in plasma concentration determined by gas chromatography-mass spectrometry (GC-MS) was observed between 2 tablets described above, so it was well accepted that nitroglycerin in tablets prepared with methylcellulose had a similar bioavailability to that in tablets prepared with lactose. The simultaneous administration of the 2 nitroglycerin tablets to a healthy volunteer, one of which containing the drug labeled with a stable isotope followed by GC-MS assay, seems to be the most suitable method for a precise comparison of bioavailability of the formulations.

UI MeSH Term Description Entries
D008297 Male Males
D008747 Methylcellulose Methylester of cellulose. Methylcellulose is used as an emulsifying and suspending agent in cosmetics, pharmaceutics and the chemical industry. It is used therapeutically as a bulk laxative. BFL,Celevac,Cellothyl,Cellulone,Citrucel,Cologel,Dacryolarmes,Methocel,Methyl Cellulose,Muciplasma,Cellulose, Methyl
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D005260 Female Females
D005996 Nitroglycerin A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives. Glyceryl Trinitrate,Anginine,Dynamite,Gilustenon,Nitrangin,Nitro-Bid,Nitro-Dur,Nitrocard,Nitroderm,Nitroderm TTS,Nitroglyn,Nitrol,Nitrolan,Nitrong,Nitrospan,Nitrostat,Perlinganit,Susadrin,Sustac,Sustak,Sustonit,Transderm Nitro,Tridil,Trinitrin,Trinitrolong,Nitro Bid,Nitro Dur,NitroBid,NitroDur,Trinitrate, Glyceryl
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
June 2020, International journal of pharmaceutics,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
January 1974, Farmatsiia,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
May 2024, International journal of pharmaceutics,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
April 2010, Drug discoveries & therapeutics,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
January 1973, Arzneimittel-Forschung,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
September 2019, AAPS PharmSciTech,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
December 2016, Carbohydrate polymers,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
November 2023, International journal of pharmaceutics,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
February 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
F Shibuya, and K Kuramoto, and H Koizumi, and N Uehara, and F Nakagawa, and Z Tamura, and M Murayama, and K Kawakubo, and T Kawahara, and M Ohshiro
September 2004, Die Pharmazie,
Copied contents to your clipboard!